RENBP and angioimmunoblastic T-cell lymphoma: Presence of anti-MAA, anti-AGE, anti-CarP and anti-AL antibodies were assessed in these subgroups, or AIH alone, and compared to non-AILD (Figures 1, 2, and Supplementary Table S3).